top of page
minila background.png
minila background.png

RISING USE

COMPLEXITY

SYSTEM GAPS

The Challenge

​​

A growing treatment population. Serious and sometimes irreversible harm. Increasing pressure on health services.

​

Ketamine is a dissociative anaesthetic with established medical uses. However, non-medical use can lead to significant physical, psychological and functional harm.

​

12×

  • Increase in adult treatment demand

  • Ketamine-related treatment entrants in England rose from 426 in 2014/15 to 5,365 in 2024/25.

​

1,465

  • Children affected

  • Under-18s receiving substance-use treatment in England who reported ketamine problems in 2024/25.

1 in 4

  • Urinary complications

  • An earlier study found that approximately a quarter of surveyed ketamine users experienced urinary symptoms, including pain, urgency and frequency.

​

Life-Changing Surgery

​

Severe ketamine-related bladder damage can become irreversible. In extreme cases, major reconstructive surgery or removal of the bladder may be necessary.

​

Low Treatment Engagement

​

A 2025 study found that only 36% of respondents who sought treatment for ketamine-related physical symptoms were satisfied with the care they received.

​

The Problem Is Not Simply Dependence

​

Ketamine-related harm does not always follow conventional patterns of addiction.

​

Significant physical or psychological harm may develop without established dependence, frequent daily use or obvious deterioration in social functioning.

​

The consequences extend beyond drug treatment, affecting urology, emergency care, mental health services, families and individuals.

​

Why a Different Response Is Needed

​

Recognising emerging harm, understanding psychological drivers and identifying changes in functioning are essential to providing timely, proportionate interventions.

​

KASPR has been developed as a research-informed, ketamine-specific framework to support structured assessment and intervention.

​​​

Sources: Office for Health Improvement and Disparities (2025), adult and children's substance misuse treatment statistics; Winstock et al. (2012), BJU International; Harding et al. (2025), Addiction; National Crime Agency (2026).

bottom of page